GE HealthCare Technologies Inc. (GEHC) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Healthcare Information Services Branche. Der Hauptsitz des Unternehmens ist in Chicago, IL, United States. Der aktuelle CEO ist Peter J. Arduini.
GEHC hat IPO-Datum 2022-12-15, 53,000 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $34.07B.
GE HealthCare Technologies Inc. is a global medical technology company headquartered in Chicago, Illinois, that develops, manufactures, and markets diagnostic imaging systems, patient monitoring solutions, and pharmaceutical contrast agents. Operating through four segments—Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics—the company serves healthcare providers across the United States, Europe, Asia, Africa, and the Middle East. Its Imaging segment offers CT, MR, X-ray, and molecular imaging systems, while its Ultrasound segment provides ultrasound solutions for radiology, cardiology, and point-of-care applications. The Patient Care Solutions segment delivers patient monitoring, anesthesia, respiratory care, and maternal infant care products and services, whereas the Pharmaceutical Diagnostics segment supplies contrast media and radiopharmaceuticals essential for diagnostic imaging procedures. Through its comprehensive portfolio of hardware, software, and digital solutions, GE HealthCare enables clinicians to diagnose, treat, and monitor patients more effectively.
